Cyclosporin A and FK506 Reduce Interleukin-5 mRNA Abundance by Inhibiting Gene Transcription

American Journal of Respiratory Cell and Molecular Biology

Volumn 17, Issue 2, 1997, Pages 243-250

  Rolfe, Fiona G ^b   Valentine, Janet E ^b   Sewell, William A ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 5; MESSENGER RNA; TACROLIMUS;

ARTICLE; CELL CULTURE; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; POLYMERASE CHAIN REACTION;

CELLS, CULTURED; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-5; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TACROLIMUS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0031203482     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.17.2.2819     Document Type: Article

References (44)

1. Gleich, G. J., and C. R. Aldolphson. 1986. The eosinophilic leukocyte: structure and function. Adv. Immunol. 39:177-253.
2. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F. B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
3. Sanderson, C. J. 1992. Interleukin 5, eosinophils and disease. Blood 79: 3101-3109.
4. Clutterbuck, E. J., E. M. Hirst, and C. J. Sanderson. 1989. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GM-CSF. Blood 73:1504-1512.
5. Ema, H., T. Suda, K. Nagayoshi, Y. Miura, C. I. Civin, and H. Nakauchi. 1990. Target cells for granulocyte colony-stimulating factor, interleukin-3 and interleukin-5 in differentiation pathways of neutrophils and eosinophils. Blood 76:1956-1961.
6. Hamid, Q., M. Azzawi, S. Ying, R. Moqbel, A. J. Wardlaw, C. J. Corrigan, B. Bradley, S. R. Durham, J. V. Collins, P. K. Jeffery, D. J. Quint, and A. B. Kay. 1991. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87:1541-1546.
7. Ying, S., S. R. Durham, C. J. Corrigan, Q. Hamid, and A. B. Kay. 1995. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am. J. Respir. Cell Mol. Biol. 12:477-487.
8. Okudaira, H., M. Nogami, G. Matsuzaki, M. Dohi, M. Suko, S. Kasuya, and K. Takatsu. 1991. T-cell-dependent accumulation of eosinophils in the lung and its inhibition by monoclonal anti-interleukin-5. Int. Arch. Allergy Appl. Immunol. 94:171-173.
9. Mauser, P. J., A. M. Pitman, X. Fernandez, S. K. Foran, G. K. Adams, W. Kreutner, R. W. Egan, and R. W. Chapman. 1995. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am. J. Respir. Crit. Care Med. 152:467-472.
10. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
11. Sigal, N. H., and F. J. Dumont. 1992. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10:519-560.
12. Fukuda, T., I. Akutsu, S. Motojima, and S. Makino. 1991. Inhibition of antigen induced late asthmatic response and bronchial hyperresponsiveness by cyclosporin and FK506. Int. Arch. Allergy Appl. Immunol. 94:259-261.
13. Norris, A. A., D. M. Jackson, and R. P. Eady. 1992. Protective effects of cyclophosphamide, cyclosporin A and FK506 against antigen induced lung eosinophilia in guinea pigs. Clin. Exp. Immunol. 89:347-350.
14. Alexander, A. G., N. C. Barnes, and A. B. Kay. 1992. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet 339:324-328.
15. Lock, S. H., A. B. Kay, and N. C. Barnes. 1996. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am. J. Respir. Crit. Care Med. 153:509-514.
16. Andersson, J., S. Nagy, C. G. Groth, and U. Andersson. 1992. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single cell level. Immunology 75:136-142.
17. Mori, A., M. Suko, Y. Nishizaki, O. Kaminuma, S. Kobayashi, G. Matsuzaki, K. Yamamoto, K. Ito, N. Tsuruoka, and H. Okudaira. 1995. IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int. Immunol. 7:449-157.
18. Rolfe, F. G., J. M. Hughes, C. L. Armour, and W. A. Sewell. 1992. Inhibition of interleukin-5 gene expression by dexamethasone. Immunology 77: 494-499.
19. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidnium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
20. Guiffre, A., K. Atkinson, and P. Kearney. 1993. A quantitative polymerase chain reaction assay for interleukin 5 messenger RNA. Anal. Biochem. 212:50-57.
21. Rolfe, F. G., and W. A. Sewell. 1997. Analysis of human interleukin-5 gene transcription by a novel nuclear run on method based on the polymerase chain reaction. J. Immunol. Methods (In press)
22. Haczku, A., A. Alexander, P. Brown, B. Assoufi, B. Li, A. B. Kay, and C. Corrigan. 1994. The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. J. Allergy Clin. Immunol. 93:510-519.
23. Atwater, J. A., R. Wisdom, and I. M. Verma. 1990. Regulated mRNA stability. Annu. Rev. Genet. 24:519-541.
24. Cockerill, P. N., M. F. Shannon, A. G. Bert, G. R. Ryan, and M. A. Vadas. 1993. The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc. Natl. Acad. Sci. USA 90:2466-2470.
25. Kronke, M., W. J. Leonard, J. Depper, S. K. Arya, F. Wong-Staal, R. Gallo, T. A. Waldmann, and W. C. Greene. 1984. Cyclosporin A inhibits T cell growth factor gene expression at the level of mRNA transcription. Proc. Natl. Acad. Sci. USA 81:5214-5218.
26. Matsuda, I., E. S. Masuda, A. Tsuboi, S. Behnam, N. Arai, and K. Arai. 1994. Characterization of NF(P), the nuclear factor that interacts with the regulatory P sequence (5′-CGAAAATTTCC-3′) of the human interleukin-4 gene: relationship to NF-κB and NF-AF. Biochem. Biophys. Res. Commun. 199:439-446.
27. Jain, J., P. G. McCaffrey, Z. Miner, T. K. Kerppola, J. N. Lambert, G. L. Verdine, T. Curran, and A. Rao. 1993. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365:352-355.
28. Northrop, J. P., K. S. Ullman, and G. R. Crabtree. 1993. Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J. Biol. Chem. 268:2917-2923.
29. Clipstone, N. A., and G. R. Crabtree. 1992. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357:695-697.
30. Fruman, D. A., C. B. Klee, B. E. Bierer, and S. J. Burakoff. 1992. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc. Natl. Acad. Sci. USA 89:3686-3690.
31. Shaw, J. P., P. J. Utz, D. B. Durand, J. J. Toole, E. A. Emmel, and G. R. Crabtree. 1988. Identification of a putative regulator of early T cell activation genes. Science 241:202-205.
32. Liu, J. 1993. FK506 and cyclosporin, molecular probes for studying intracellular signal transduclion. Immunol. Today 14:290-295.
33. Lee, H. J., E. S. Masuda, N. Arai, K.-I. Arai, and T. Yokota. 1995. Definition of cis-regulatory elements of the mouse interleukin-5 gene promoter. J. Biol. Chem. 270:17541-17550.
34. Karlen, S., M. Dercole, and C. J. Sanderson. 1996. Two pathways can activate the interleukin-5 gene and induce binding to the conserved lymphokine element 0. Blood 88:211-221.
35. Naora, H., and I. G. Young. 1994. Mechanisms regulating the mRNA levels of interleukin-5 and two other coordinately expressed lymphokines in the murine T lymphoma EL4.23. Blood 83:3620-3628.
36. Beadling, C., D. Guschin, B. A. Whitthuhn, A. Ziemiecki, J. N. Ihle, I. M. Keer, and D. A. Cantrell. 1994. Activation of JAK kinases and STAT proteins by IL2 and IFNα, but not the T cell antigen receptor, in human T lymphocytes. EMBO J. 13:5605-5615.
37. Mills, G., R. Cheung, S. Grinstein, and E. Gelfand. 1985. Interleukin 2 induced lymphocyte proliferation is independent of increases in cytosolic-free calcium concentrations. J. Immunol. 134:2431-2435.
38. Karlsson, H., L. Truedsson, and L. Nassberger. 1991. The immunosuppressive agent FK506 inhibits in vitro expression of membrane bound and soluble IL2 receptors on resting but not on activated human lymphocytes. Immunol. Lett. 30:124-132.
39. Kaye, R. F.., D. A. Fruman, B. E. Bierer, M. W. Albers, L. D. Zydowsky, S. I. Ho, Y. J. Jin, M. C. Castells, S. L. Schreiber, C. T. Walsh, S. J. Burakoft, K. F. Austen, and H. R. Katz. 1992. Effects of cyclosporin A and FK506 on Fc epsilon receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. Proc. Natl. Acad. Sci. USA 89:8542-8546.
40. Hanke, J. H., L. N. Nichols, and M. E. Coon. 1992. FK506 and Rapamycin selectively enhance degradation of IL-2 and GM-CSF mRNA. Lymphokine Cytokine Res. 11:221-231.
41. Nair, A. P., S. Hahn, R. Banholzer, H. H. Hirsch, and C. Moroni. 1944. Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA. Nature 369:239-242.
42. Iwai, Y., K. Akahane, D. H. Pluznik, and R. B. Cohen. 1993. Calcium ionophore A23187-dependent stabilisation of granulocyte-macrophage colony-stimulating factor messenger RNA in murine thymoma EL-4 cells is mediated through two distinct regions in the 3′-untranslated region. J. Immunol. 150:4386-4344.
43. Akashi, M., G. Shaw, M. Hachiya, E. Elstner, G. Suzuki, and P. Koeffler. 1994. Number and location of AUUUA motifs: role in regulating transiently expressed RNAs. Blood 83:3182-3187.
44. Valentine, J. E., and W. A. Sewer. 1997. Induction of IL-5 expression by IL-2 is resistant to the immunosuppressive agents cyclosporin A and rapamycin. Int. Immunol. (In press)